- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05803109
Efficacy of Coconut Oil With Peppermint Essential for Oral Hygiene Routine
May 7, 2025 updated by: Asmaa Mohamed Reda Ahmed Ali, Cairo University
Efficacy of Extra Virgin Cold Pressed Coconut Oil With Peppermint Essential Oil as Natural Cleaning Agent for Oral Hygiene Routine on Salivary Streptococcus Mutant Levels Versus The Conventional Oral Hygiene Methods in High Caries Risk Patients: A Randomized Clinical Trial
This randomized clinical trial will be conducted to investigate the efficacy of an innovative tooth cleaning agent extra virgin coconut oil with peppermint essential oil by oil pulling and toothbrushing with oil on reducing salivary Streptococcus mutans levels, tooth decay and plaque buildup versus on the counter toothpaste in high caries risk patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Everyday use of dental health care products has increased.
Therefore, there is a legitimately increased interest of healthcare clinicians and consumers in substances added to the toothpaste with the intention to improve their performance and potential benefits and risks that may arise from it.
As there are harmful products in the toothpaste for instance: (Fluoride, Sodium Lauryl Sulphate (SLS), Sodium Saccharin and Triclosan which is assumed that it because local reaction includes oral mucosa irritation and desquamation (stomatitis, glossitis, gingivitis, buccal mucositis), while systemic ones are allergic and acute or chronic toxic reactions.
Rational Harmful products in the toothpaste for instance: (Fluoride, Sodium Lauryl Sulphate (SLS), Sodium Saccharin and Triclosan which is assumed that it because local reaction includes oral mucosa irritation and desquamation (stomatitis, glossitis, gingivitis, buccal mucositis), while systemic ones are allergic and acute or chronic toxic reactions.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kasr El Ainy
-
Cairo, Kasr El Ainy, Egypt, 12613
- Faculty of Dentistry Cairo University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Patients will be recruited in this study, will be medically free.
- Age range 20-50 years
- Patients with high caries risk assessment (0- 30% high caries risk) according to Cariogram - a multifactorial risk assessment model for dental caries.
- Non-Smoking patients
- Not under antibiotic therapy either at the time of the study or up to the last month before the start of the study.
- Male or Female patients
- Patients have brushing habits
- No Fixed orthodontic treatment
- No active or untreated caries
- Patients on non-cariogenic diet
Exclusion Criteria:
- Patients with a compromised medical history.
- Patients with low caries risk assessment according to Cariogram - a multifactorial risk assessment model for dental caries.
- Patients with severe or active periodontal disease.
- Patients with a history of allergy to any of the drugs or chemicals will be used in the study.
- Patients on any antibiotics during the past month.
- Smoking patient
- Patients with very low saliva secretion xerostomia less than 0.5ml stimulated saliva /min score 3 according to Cariogram
- Pregnant female patient
- No brushing habits
- Fixed orthodontic treatment
- Active or untreated caries
- Patients on cariogenic diet
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: virgin cold-pressed coconut oil with Peppermint essential oil
Patients will be instructed to use one packet of the coco pull healthy blend of organic oil (virgin cold pressed coconut oil with Peppermint essential oil)and swish the oil in the mouth and pull it between teeth for 5 minutes then spit out the oil and brush their teeth with the oil for 2 minutes; such a regimen will be repeated twice daily for three months.
|
virgin cold pressed coconut oil with Peppermint essential oil
|
|
Active Comparator: The fluoride toothpaste (Colgate Total,
Patients will be instructed to brush their teeth with the fluoride toothpaste (Colgat Total, 1450 ppm) for 2 minutes; such a regimen will be repeated two times daily for three months and use 10 ml of 0.12% chlorhexidine rinse for 1 min/day, 30 min after tooth brushing before going to bed.
|
virgin cold pressed coconut oil with Peppermint essential oil
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the actual chance to avoid new lesion will be assessed
Time Frame: T0: Baseline. T1: After one month. T2: After three months
|
The Measuring test: Cariogram Model (Karabekiroğlu et al 2017), The Measuring units : Percentage
|
T0: Baseline. T1: After one month. T2: After three months
|
|
Change in the bacterial count will be assessed
Time Frame: T0: Baseline. T1: After one month. T2: After three months
|
The measuring test:Colony forming unit, The measuring units : Cfu/mm2 (Prabakar et al., 2018)
|
T0: Baseline. T1: After one month. T2: After three months
|
|
Change in the salivary pH will be assessed
Time Frame: T0: Baseline. T1: After one month. T2: After three months
|
The measuring test: Digital pH meter, The measuring unit : Scoring system, (Sondos et al., 2019) (ordinal)
|
T0: Baseline. T1: After one month. T2: After three months
|
|
Change in the Plaque index will be assessed Löe-Silness (Loe 1963)
Time Frame: T0: Baseline. T1: After one month. T2: After three months
|
The measuring unit : Plaque index The oral hygiene and plaque amount will be estimated using a mirror and graduated periodontal probe in accordance with Silness and Löe plaque index, which assessed the amount of plaque in the cervical part of the tooth.The Plaque Index System
Löe-Silness (Loe 1963) (Sreenivasan et al.,2016), The Measuring units : Scoring system (ordinal) |
T0: Baseline. T1: After one month. T2: After three months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the Bacterial virulence will be assessed
Time Frame: T0: Baseline. T1: After one month. T2: After three months
|
The Measuring test: Streptococcus mutans acidogenicity by Digital pH meter ,the maximum value is 7.2 less than it is bad value (Bedoya-Correa et al., 2021),the measuring units : Scoring system (ordinal)
|
T0: Baseline. T1: After one month. T2: After three months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 21, 2024
Primary Completion (Actual)
January 1, 2025
Study Completion (Actual)
January 1, 2025
Study Registration Dates
First Submitted
January 28, 2023
First Submitted That Met QC Criteria
March 26, 2023
First Posted (Actual)
April 7, 2023
Study Record Updates
Last Update Posted (Actual)
May 11, 2025
Last Update Submitted That Met QC Criteria
May 7, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- CairoU 4 7 22
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fluoride Adverse Reaction
-
Galeno Desenvolvimento de Pesquisas ClínicasBiolab Sanus FarmaceuticaCompletedLidocaine Adverse Reaction | Prilocaine Adverse ReactionBrazil
-
Wonkwang University HospitalCompletedKetamine Adverse Reaction | Propofol Adverse Reaction | Dream, DayKorea, Republic of
-
The Leeds Teaching Hospitals NHS TrustLeeds Clinical Commissioning GroupRecruitingAdherence, Medication | Statin Adverse Reaction | Anticoagulant Adverse ReactionUnited Kingdom
-
Rigshospitalet, DenmarkCompletedAnalgesic Adverse Reaction | Gonad Regulating Hormone Adverse ReactionDenmark
-
Clinical Hospital Center ZemunWithdrawnBisoprolol Adverse Reaction | Nebivolol Adverse ReactionSerbia
-
PT Bio FarmaCenter for Child Health Universitas Gadjah Mada (CCH-PRO UGM; Cipto Mangunkusumo... and other collaboratorsCompletedVaccine Adverse Reaction | Vaccine ReactionIndonesia
-
Giresun UniversityCompletedLidocaine Adverse Reaction | Rocuronium Adverse ReactionTurkey
-
University of Texas Southwestern Medical CenterRecruitingAnesthesia | Anesthesia; Reaction | Anesthesia Complication | Anesthesia; Adverse Effect | Propofol Adverse Reaction | Etomidate Adverse ReactionUnited States
-
Izmir Ataturk Training and Research HospitalNot yet recruitingPsychotropic Agents Causing Adverse Effects in Therapeutic Use | Anticholinergic Adverse Reaction | Anticholinergic Syndrome | Antiarrhythmic Drug Adverse Reaction | Antiparkinsonism Drugs Causing Adverse Effects in Therapeutic Use | Antispasmodic Adverse Reaction
-
Shanghai Yueyang Integrated Medicine HospitalRecruiting
Clinical Trials on AVIVA-PURE-CocoPull-Organic-made in USA
-
Purdue UniversityCompletedObesity | Diabetes Mellitus, Type 2 | Appetitive BehaviorUnited States